FTC Files Amicus Brief to Protect Competition in Biologic Drug Markets
Date
The Federal Trade Commission filed an amicus brief in an antitrust case alleging that drug manufacturer Amgen illegally acquired exclusive rights to patent applications that it shaped to cover Enbrel...